Literature DB >> 9370872

How do bisphosphonates prevent fractures?

J H Tobias1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9370872      PMCID： PMC1752440          DOI： 10.1136/ard.56.9.510

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis.

Authors:  A M Parfitt
Journal:  Calcif Tissue Int       Date:  1979-08-24       Impact factor: 4.333

2.  Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.

Authors:  T Storm; G Thamsborg; T Steiniche; H K Genant; O H Sørensen
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

3.  Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis.

Authors:  H Oxlund; L Mosekilde; G Ortoft
Journal:  Bone       Date:  1996-11       Impact factor: 4.398

4.  Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength.

Authors:  L Mosekilde; L Mosekilde
Journal:  Bone       Date:  1986       Impact factor: 4.398

5.  The thickness of human vertebral cortical bone and its changes in aging and osteoporosis: a histomorphometric analysis of the complete spinal column from thirty-seven autopsy specimens.

Authors:  H Ritzel; M Amling; M Pösl; M Hahn; G Delling
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

Review 6.  Bone microdamage and skeletal fragility in osteoporotic and stress fractures.

Authors:  D B Burr; M R Forwood; D P Fyhrie; R B Martin; M B Schaffler; C H Turner
Journal:  J Bone Miner Res       Date:  1997-01       Impact factor: 6.741

7.  The renal clearance of free and conjugated pyridinium cross-links of collagen.

Authors:  A Colwell; R Eastell
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

8.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Authors:  D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud
Journal:  Lancet       Date:  1996-12-07       Impact factor: 79.321

9.  Neridronate preferentially suppresses the urinary excretion of peptide-bound deoxypyridinoline in postmenopausal women.

Authors:  J H Tobias; C V Laversuch; N Wilson; S P Robins
Journal:  Calcif Tissue Int       Date:  1996-11       Impact factor: 4.333

10.  Microradiographic aspect on iliac bone tissue in postmenopausal women with and without vertebral crush fractures.

Authors:  B Flautre; P Hardouin
Journal:  Bone       Date:  1994 Sep-Oct       Impact factor: 4.398
View more
  1 in total

1.  Pamidronate treatment of pediatric fracture patients on chronic steroid therapy.

Authors:  Philip D Acott; Jaime A Wong; Bianca A Lang; John F S Crocker
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.